NU SKIN ENTERPRISES, INC. has reported its financial condition and results of operations in its latest 10-K filing with the SEC. Here are the key highlights from the report:
-
NU SKIN generated $80.3 million in cash from operations in 2025, compared to $111.7 million in 2024, primarily reflecting cash payments made in the first quarter of 2025 related to expenses accrued as of year-end, including restructuring and other accrued expenses.
-
As of December 31, 2025, cash and cash equivalents, including current investments, were $239.8 million compared to $198.0 million as of December 31, 2024, driven by the proceeds from the sale of Mavely and cash generated from operations.
-
Working capital as of December 31, 2025, was $284.0 million compared to $242.0 million as of December 31, 2024, primarily attributable to the increase in cash.
-
NU SKIN expects its material cash requirements for 2026 to include cash requirements for operating activities, investing activities, and financing activities.
-
The company anticipates capital expenditures of approximately $40-60 million for 2026, primarily related to the Rhyz plant expansion, purchases and expenditures for computer systems and equipment, software, and application development, and the expansion and upgrade of facilities in various markets.
-
In 2025, NU SKIN repurchased 2.0 million shares of its Class A common stock under the stock repurchase plan for $20.0 million. As of December 31, 2025, $142.3 million was available for repurchases under the plan.
-
Quarterly cash dividends of $0.06 per share were paid in 2025, and the board of directors declared a quarterly cash dividend of $0.06 per share to be paid in March 2026.
-
The company held $239.8 million in cash and cash equivalents as of December 31, 2025, including $170.7 million held in operations outside of the United States.
-
NU SKIN believes that existing cash balances, future cash flows from operations, and existing lines of credit will be adequate to fund its cash needs on both a short* and long-term basis.
-
The company reported a non-GAAP financial measure, constant-currency revenue change, to remove the impact of fluctuations in foreign-currency exchange rates, enabling period-to-period comparisons of its performance.
-
NU SKIN highlighted seasonal factors and trends, such as major cultural events and vacation patterns, impacting its business, and the impact of product introductory offerings on revenue and sales.
-
The report also includes information regarding contingent liabilities and recent accounting pronouncements.
These details provide a comprehensive overview of NU SKIN's financial condition, cash flows, capital expenditures, and other key aspects of its operations as outlined in the 10-K filing. As a result of these announcements, the company's shares have moved 1.76% on the market, and are now trading at a price of $11.54. Check out the company's full 10-K submission here.
